BeStock  
Stocks › Biotechnology › KURA

Kura Oncology KURA

US equityMarket cap rank #3276Biotechnology
$10.67 +$0.14 (+1.33%)
Pre-market · Oct 8, 9:10 am ET · After hours $10.67 0.00%
Open$10.43
Prev close$10.53
Day range$10.32 – $10.99
Volume1.10M
Market cap$949.21M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-3.2x
CheapRich

Near the top of its 5-year range · 85th percentile, 5-year average -5.9x

Price / book19.6x
CheapRich

Near the top of its 5-year range · 97th percentile, 5-year average 3.3x

#5104 of 5317 stocks by PB (1 = cheapest)

Price / sales12.3x
CheapRich

Near the top of its 5-year range · 94th percentile, 5-year average 3.2x

#4499 of 5146 stocks by PS (1 = cheapest)

P/E over five years

-12x-8x-5x-2xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$15.69
Price vs. fair value-32.0%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 19.61 – 3.30 97% (pricier than usual) #5104 of 5317 (1 = cheapest)
PE -3.17 -3.68 -5.88 85% (pricier than usual) –
PS 12.29 6.47 3.23 94% (pricier than usual) #4499 of 5146 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★★
Fair value estimate$15.69
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on KURA.

Leave a comment

Scroll to Top